Mourant Ozannes advises on HK$700 million healthcare acquisition
14 December 2017
Mourant Ozannes' Hong Kong practice has advised on the HK$700 million acquisition of shares in Biostime Pharmaceuticals (China) Limited, a controlling shareholder of Health and Happiness (H&H) International Holdings Limited (H&H), by Coliving Limited (Coliving) from certain other shareholders. H&H is a leading provider of baby nutrition, care and vitamins and supplements and is listed on the Hong Kong Stock Exchange.
The team advised on the BVI and Cayman Islands law aspects of the acquisition, which resulted in Coliving becoming the indirect controlling shareholder of H&H, and also advised in connection with the financing arrangements relating to the acquisition.
The Mourant Ozannes team, led by banking and finance partner, Danielle Roman and associate, Peter Vas, acted as offshore counsel to Coliving alongside a leading international law firm in Hong Kong.
Contact
About Mourant
Mourant is a law firm-led, professional services business with over 60 years' experience in the financial services sector. We advise on the laws of the British Virgin Islands, the Cayman Islands, Guernsey, Jersey and Luxembourg and provide specialist entity management, governance, regulatory and consulting services.
